CHROMOSOMAL COMPLEMENTATION OF BLOOM SYNDROME CELLS
Project Number2R01CA052121-04A1
Contact PI/Project LeaderSCHULTZ, ROGER A.
Awardee OrganizationUT SOUTHWESTERN MEDICAL CENTER
Description
Abstract Text
Bloom syndrome (BSx) is an autosomal recessive disorder exhibiting a
constellation of clinical features including proportional dwarfing,
chronic infections, and a significant predisposition to the development of
cancer. cytologically, this disease exhibits a many-fold increase in the
occurrence of spontaneous chromosome breakage and sister chromatid
exchanges (SCEs), the latter being diagnostic. Subtle biochemical
alterations have been detected in BSx cells, but reflect consequences
secondary to the elusive primary defect. Genetic analyses clearly
demonstrate that BSx is a single gene defect. Linkage mapping has been
compromised by rare occurrence, by poor family collections, and by a lack
of availability of those limited materials which have been collected.
Microcell-mediated chromosome transfer (MMCT) offers an alternative
mapping approach in which individual normal human chromosomes are
transferred from somatic cell hybrids into defective cells to demonstrate
phenotypic complementation. Correction of the elevated SCE and chromosome
breakage phenotypes of BSx cells coincides with introduction of human
chromosome 15. Somatic cell hybrids possessing deletions of chromosome 15
have refined MMCT mapping to l5q23-q26. These mapping data are supported
by recent genetic linkage results of others which map the BSx disease to
l5q26.l. This application proposes the cloning and characterization of the
BSx gene. Genomic clones (cosmids and YACs) representing this 15q26.1
region will be identified and assessed for their ability to complement BSx
cells. Concurrently, several innovative approaches (focusing principally
on MMCT of additional chromosome IS deletions) will be used to confirm and
further refine mapping of the BSx locus. Identification of the BSx
complementing genomic clone will permit isolation of a cDNA. Comparisons
of mRNA levels and cDNA sequencing data from normal and BSx alleles should
confirm this locus to be the primary defect for this disorder.
Characterization of this gene and its protein should provide insights into
mechanisms which influence recombination, SCE formation, chromosome
breakage, and predilection to neoplasia.
No Sub Projects information available for 2R01CA052121-04A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01CA052121-04A1
Patents
No Patents information available for 2R01CA052121-04A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01CA052121-04A1
Clinical Studies
No Clinical Studies information available for 2R01CA052121-04A1
News and More
Related News Releases
No news release information available for 2R01CA052121-04A1
History
No Historical information available for 2R01CA052121-04A1
Similar Projects
No Similar Projects information available for 2R01CA052121-04A1